Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
FZMD US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Fuse Medical, Inc.
(FZMD US)
$0.03
+0.00
0.00%
(Market Open · 21:00:00 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
FZMD US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Fuse Medical, Inc.
(FZMD US)
$0.03
+0.00
0.00%
(Market Open · 21:00:00 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
SEC Filings
SEC Filings
Select Filings
Financials
(141)
Expand
10-Q
Q2
ended 30 Jun 2023
14 Aug 2023
10-Q
Q1
ended 31 Mar 2023
15 May 2023
10-K
FY 2022
ended 31 Dec 2022
14 Apr 2023
NT 10-K
FY 2022
ended 31 Dec 2022
3 Apr 2023
10-Q
Q3
ended 30 Sept 2022
14 Nov 2022
10-Q
Q2
ended 30 Jun 2022
11 Aug 2022
10-Q
Q1
ended 31 Mar 2022
12 May 2022
10-K
FY 2021
ended 31 Dec 2021
31 Mar 2022
10-Q
Q3
ended 30 Sept 2021
10 Nov 2021
10-Q
Q2
ended 30 Jun 2021
12 Aug 2021
10-Q
Q1
ended 31 Mar 2021
12 May 2021
10-Q
Q3
ended 30 Sept 2020
16 Nov 2020
10-Q
Q2
ended 30 Jun 2020
7 Aug 2020
10-Q
Q1
ended 31 Mar 2020
22 May 2020
NT 10-Q
Q1
ended 31 Mar 2020
15 May 2020
Events
(85)
Expand
8-K
Results of Operations and Financial Condition
27 Sep 2023
8-K
Results of Operations and Financial Condition
15 Aug 2023
8-K
Submission of Matters to Shareholder Vote
26 Jun 2023
8-K
FOR IMMEDIATE RELEASE
18 Apr 2023
8-K
Change in Certifying Accountant
22 Nov 2022
8-K
September 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,492
18 Nov 2022
8-K
Submission of Matters to Shareholder Vote
28 Jun 2022
8-K
Director/Officer Changes & Compensatory Arrangements
8 Apr 2022
8-K
New Financial Obligation or Off-Balance Sheet Arrangement
20 Dec 2021
8-K
Director/Officer Changes & Compensatory Arrangements
3 Dec 2021
8-K
Entry into Material Agreement
12 Nov 2021
8-K
Submission of Matters to Shareholder Vote
10 Jun 2021
8-K
Other Events
1 Feb 2021
8-K
Other Events
20 Jan 2021
8-K
Other Events
22 Dec 2020
Insider Ownership
(90)
Expand
Form 4
Reeg Christopher C
16 Dec 2022
Form 4
Brooks Mark W
16 Dec 2022
Form 4
Yellin Lawrence Scott
16 Dec 2022
Form 4
Brooks Mark W
17 Nov 2022
Form 3
Yellin Lawrence Scott
26 May 2022
Form 5
Reeg Christopher C
23 Feb 2022
Form 5
Brooks Mark W
23 Feb 2022
Form 4
Bosita Renato V. Jr.
21 Dec 2018
Form 4
Kalra Ricky Raj S.
14 Dec 2018
Form 4
Brooks Mark W
14 Dec 2018
Form 4
Reeg Christopher C
14 Dec 2018
Form 4
McLaughlin William E III
14 Dec 2018
Form 4/A
Reeg Medical Industries, Inc.
27 Nov 2018
Form 4/A
Reeg Christopher C
27 Nov 2018
Form 4
Reeg Medical Industries, Inc.
3 Aug 2018
Beneficial Ownership
(19)
Expand
SC 13D/A
Fuse Medical, Inc.
13 Aug 2018
SC 13D/A
Fuse Medical, Inc.
13 Aug 2018
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13G/A
Fuse Medical, Inc.
17 Feb 2015
SC 13D
Fuse Medical, Inc.
9 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13G/A
GOLF ROUNDS COM INC
3 Feb 2014
SC 13G
GOLF ROUNDS COM INC
6 Jan 2012
SC 13D/A
GOLF ROUNDS COM INC
31 Jul 2003
SC 13D
GOLF ROUNDS COM INC
1 Jul 2002
Proxies
(27)
Expand
DEFA14A
Definitive additional materials
10 May 2023
ARS
Annual report to security holders
10 May 2023
DEF 14A
Definitive proxy statement
10 May 2023
DEFA14A
Definitive additional materials
10 May 2022
DEF 14A
Definitive proxy statement
10 May 2022
DEFA14A
Definitive additional materials
27 Apr 2021
DEF 14A
Definitive proxy statement
27 Apr 2021
DEFA14A
Definitive additional materials
27 Apr 2020
DEF 14A
Definitive proxy statement
27 Apr 2020
DEFA14A
Definitive additional materials
5 Jun 2019
DEFA14A
Definitive additional materials
13 May 2019
DEF 14A
Definitive proxy statement
13 May 2019
PRE 14A
PRELIMINARY PROXY STATEMENT
2 May 2019
DEFA14C
Definitive additional information statement
28 Dec 2018
DEF 14C
Definitive information statement
28 Dec 2018
Registrations
(3)
Expand
15-12G
Notice of suspension of duty to file
27 Sep 2023
S-8
Registration statement (employee benefit plan)
8 Jan 2019
S-8
Registration statement (employee benefit plan)
11 Oct 2017
Filing Review Correspondence
(4)
Expand
CORRESP
Filing review correspondence
27 Aug 2018
CORRESP
Filing review correspondence
27 Aug 2018
CORRESP
Filing review correspondence
6 Jun 2018
CORRESP
Filing review correspondence
11 May 2018
SEC Orders And Notices
(3)
Expand
CT ORDER
Confidential treatment order
24 Aug 2015
CT ORDER
Confidential treatment order
21 Oct 2014
CT ORDER
Confidential treatment order
21 Oct 2014
Tender Offers And Going Private
(2)
Expand
SC 14F1
SCHEDULE 14F-1
16 Aug 2013
SC 14F1
Information statement (change in majority)
21 Jan 2000
Exempt Offerings
(4)
Expand
D
06b
21 Aug 2018
D
06b
25 Oct 2017
D
06b
4 Jan 2017
D
06b
4 Jun 2014
Other
(4)
Expand
NTN 10Q
NTN 10Q
14 Jul 2014
NTN 10Q
FORM 12B-25
17 Jan 2001
10KSB40
10KSB40
14 Dec 2000
NTN 10Q
FORM 12B-25
30 Nov 2000
Select Filings
Financials
(141)
Expand
10-Q
Q2
ended 30 Jun 2023
14 Aug 2023
10-Q
Q1
ended 31 Mar 2023
15 May 2023
10-K
FY 2022
ended 31 Dec 2022
14 Apr 2023
NT 10-K
FY 2022
ended 31 Dec 2022
3 Apr 2023
10-Q
Q3
ended 30 Sept 2022
14 Nov 2022
10-Q
Q2
ended 30 Jun 2022
11 Aug 2022
10-Q
Q1
ended 31 Mar 2022
12 May 2022
10-K
FY 2021
ended 31 Dec 2021
31 Mar 2022
10-Q
Q3
ended 30 Sept 2021
10 Nov 2021
10-Q
Q2
ended 30 Jun 2021
12 Aug 2021
10-Q
Q1
ended 31 Mar 2021
12 May 2021
10-Q
Q3
ended 30 Sept 2020
16 Nov 2020
10-Q
Q2
ended 30 Jun 2020
7 Aug 2020
10-Q
Q1
ended 31 Mar 2020
22 May 2020
NT 10-Q
Q1
ended 31 Mar 2020
15 May 2020
Events
(85)
Expand
8-K
Results of Operations and Financial Condition
27 Sep 2023
8-K
Results of Operations and Financial Condition
15 Aug 2023
8-K
Submission of Matters to Shareholder Vote
26 Jun 2023
8-K
FOR IMMEDIATE RELEASE
18 Apr 2023
8-K
Change in Certifying Accountant
22 Nov 2022
8-K
September 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,492
18 Nov 2022
8-K
Submission of Matters to Shareholder Vote
28 Jun 2022
8-K
Director/Officer Changes & Compensatory Arrangements
8 Apr 2022
8-K
New Financial Obligation or Off-Balance Sheet Arrangement
20 Dec 2021
8-K
Director/Officer Changes & Compensatory Arrangements
3 Dec 2021
8-K
Entry into Material Agreement
12 Nov 2021
8-K
Submission of Matters to Shareholder Vote
10 Jun 2021
8-K
Other Events
1 Feb 2021
8-K
Other Events
20 Jan 2021
8-K
Other Events
22 Dec 2020
Insider Ownership
(90)
Expand
Form 4
Reeg Christopher C
16 Dec 2022
Form 4
Brooks Mark W
16 Dec 2022
Form 4
Yellin Lawrence Scott
16 Dec 2022
Form 4
Brooks Mark W
17 Nov 2022
Form 3
Yellin Lawrence Scott
26 May 2022
Form 5
Reeg Christopher C
23 Feb 2022
Form 5
Brooks Mark W
23 Feb 2022
Form 4
Bosita Renato V. Jr.
21 Dec 2018
Form 4
Kalra Ricky Raj S.
14 Dec 2018
Form 4
Brooks Mark W
14 Dec 2018
Form 4
Reeg Christopher C
14 Dec 2018
Form 4
McLaughlin William E III
14 Dec 2018
Form 4/A
Reeg Medical Industries, Inc.
27 Nov 2018
Form 4/A
Reeg Christopher C
27 Nov 2018
Form 4
Reeg Medical Industries, Inc.
3 Aug 2018
Beneficial Ownership
(19)
Expand
SC 13D/A
Fuse Medical, Inc.
13 Aug 2018
SC 13D/A
Fuse Medical, Inc.
13 Aug 2018
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13D
Fuse Medical, Inc.
29 Dec 2016
SC 13G/A
Fuse Medical, Inc.
17 Feb 2015
SC 13D
Fuse Medical, Inc.
9 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13D
Fuse Medical, Inc.
6 Jun 2014
SC 13G/A
GOLF ROUNDS COM INC
3 Feb 2014
SC 13G
GOLF ROUNDS COM INC
6 Jan 2012
SC 13D/A
GOLF ROUNDS COM INC
31 Jul 2003
SC 13D
GOLF ROUNDS COM INC
1 Jul 2002
Proxies
(27)
Expand
DEFA14A
Definitive additional materials
10 May 2023
ARS
Annual report to security holders
10 May 2023
DEF 14A
Definitive proxy statement
10 May 2023
DEFA14A
Definitive additional materials
10 May 2022
DEF 14A
Definitive proxy statement
10 May 2022
DEFA14A
Definitive additional materials
27 Apr 2021
DEF 14A
Definitive proxy statement
27 Apr 2021
DEFA14A
Definitive additional materials
27 Apr 2020
DEF 14A
Definitive proxy statement
27 Apr 2020
DEFA14A
Definitive additional materials
5 Jun 2019
DEFA14A
Definitive additional materials
13 May 2019
DEF 14A
Definitive proxy statement
13 May 2019
PRE 14A
PRELIMINARY PROXY STATEMENT
2 May 2019
DEFA14C
Definitive additional information statement
28 Dec 2018
DEF 14C
Definitive information statement
28 Dec 2018
Registrations
(3)
Expand
15-12G
Notice of suspension of duty to file
27 Sep 2023
S-8
Registration statement (employee benefit plan)
8 Jan 2019
S-8
Registration statement (employee benefit plan)
11 Oct 2017
Filing Review Correspondence
(4)
Expand
CORRESP
Filing review correspondence
27 Aug 2018
CORRESP
Filing review correspondence
27 Aug 2018
CORRESP
Filing review correspondence
6 Jun 2018
CORRESP
Filing review correspondence
11 May 2018
SEC Orders And Notices
(3)
Expand
CT ORDER
Confidential treatment order
24 Aug 2015
CT ORDER
Confidential treatment order
21 Oct 2014
CT ORDER
Confidential treatment order
21 Oct 2014
Tender Offers And Going Private
(2)
Expand
SC 14F1
SCHEDULE 14F-1
16 Aug 2013
SC 14F1
Information statement (change in majority)
21 Jan 2000
Exempt Offerings
(4)
Expand
D
06b
21 Aug 2018
D
06b
25 Oct 2017
D
06b
4 Jan 2017
D
06b
4 Jun 2014
Other
(4)
Expand
NTN 10Q
NTN 10Q
14 Jul 2014
NTN 10Q
FORM 12B-25
17 Jan 2001
10KSB40
10KSB40
14 Dec 2000
NTN 10Q
FORM 12B-25
30 Nov 2000
Ask in Filing
Ask in Filing
